Impact of Artificial Intelligence-based Patient Reinforcement on Quality of Colonoscopy

NCT ID: NCT05041283

Last Updated: 2021-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

258 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-21

Study Completion Date

2022-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In order to improve bowel preparation for colonoscopy and consequently enhance detection rate of malignant and premalignant findings, a prospective, randomized and controlled three-arm study was developed. Patients who undergo ambulatory colonoscopy are randomly assigned into a control group with standard preparation, a phone call supported preparation group or a group supported by an artificial intelligence based chatbot. Primary endpoint is defined as quality of bowel preparation (Boston Bowel Preparation Score), secondary endpoints are patients satisfaction, comprehensiveness of bowel preparation, sedation dose, rate of coecal intubation and the rate of adenoma and polyp detection, anxiety referred to colonoscopy and patients satisfaction with preparation support.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Adequate bowel preparation is crucial for detection of adenoma and polyps of the colon, which can transform into malignant and premalignant lesions. In particular ambulatory performed colonoscopy is often insufficient due to inadequate preparation by patients at home. To focus this issue, a artificial intelligence based chatbot was developed to help patients who undergo bowel preparation by answering questions concerning bowel preparation. To compare the effect of this program, a three-arm randomized, controled multicentric clinical trial was developed. All patients who undergo ambulatory colonoscopy and meet the inclusion criteria (18 y.o., informed consent, WhatsApp access) were randomized in a standard preparation group (medical briefing and preparation brochure), a group receiving phone calls with instructions for bowel preparation and a third group with access to the chat bot answering questions concerning bowel preparation and examination conduct. As the primary end point, the quality of bowel preparation measured as Boston Bowel Preparation Scale was defined. As secondary endpoints patients satisfaction, comprehensiveness of bowel preparation, sedation dose, rate of coecal intubation, the rate of adenoma and polyp detection, anxiety referred to colonoscopy and patients satisfaction with preparation support were measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bowel Preparation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Preparation

Control arm; patients receive a standard support for bowel preparation consisting of a explanatory dialogue with a gastroenterologist and a brochure with a structurated description of bowel preparation and colonoscopy conduct

Group Type NO_INTERVENTION

No interventions assigned to this group

Phone-call Supported Preparation

In addition to standard preparation, patients receive a phone call every day starting at 3 days before colonoscopy in which a investigator explains key points of bowel preparation and patients can ask questions concerning bowel preparation and colonoscopy conduct.

Group Type ACTIVE_COMPARATOR

Phone call

Intervention Type OTHER

A phone call is performed every day starting at 3 days before colonoscopy to support bowel preparation.

Chatbot Supported Preparation

In addition to standard preparation, patients receive an access to a chatbot which can be contacted via Whats App starting at 3 days before colonoscopy. The chatbot is programed to answer questions concerning bowel preparation and colonoscopy conduct.

Group Type EXPERIMENTAL

Chatbot

Intervention Type OTHER

A artificial-intelligence based chatbot is provided 3 days before colonoscopy to answer questions concerning bowel preparation and colonoscopy conduct.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chatbot

A artificial-intelligence based chatbot is provided 3 days before colonoscopy to answer questions concerning bowel preparation and colonoscopy conduct.

Intervention Type OTHER

Phone call

A phone call is performed every day starting at 3 days before colonoscopy to support bowel preparation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* informed consent
* smartphone with access to WhatsApp
* indication for ambulatory colonoscopy
* ASA I or II

Exclusion Criteria

* no informed consent given or possible
* no access to a smartphone with WhatsApp
* \<18 years old
* Pregnancy/Lactation
* Allergy to Moviprep©
* ASA (American Society of Anesthesiologists) state \>II
* extended abdominal surgery in past history
* no indication for ambulatory colonoscopy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Ulm

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Thomas Seufferlein

Prof. Dr. med.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Seufferlein, Prof.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Ulm

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Specialist Practice Profes. Dikopoulos/Ludwig

Ulm, Baden-Würrtemberg, Germany

Site Status RECRUITING

University of Ulm, Interdisciplinary Endoscopy

Ulm, Baden-Würrtemberg, Germany

Site Status RECRUITING

Specialist Practice

Berlin, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Benjamin Walter, MD

Role: CONTACT

+49731/5000

Niklas Sturm, MD

Role: CONTACT

+49731/5000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nektarios Dikopoulos, Prof.

Role: primary

+497348 9671747

Leopold Ludwig, Prof.

Role: backup

+497348 9671747

benjamin Walter, MD

Role: primary

+497315000

Jens Aschenbeck, MD

Role: primary

+4930 - 331 44 44

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ARCHES

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.